Evidence map›Paper›PMID 38949120›Full record

ReviewFASEB journal : official publication of the Federation of American Societies for Experimental Biology2024

Mechanisms of triple-negative breast cancer extravasation: Impact of the physical environment and endothelial glycocalyx.

Chinedu C Okorafor, Sanjana Shastri, Ke Wen, Eno E Ebong

Abstract readReview
In one paragraph

Review in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chinedu C OkoraforDepartment of Chemical Engineering, Northeastern University, Boston, Massachusetts, USA.ORCID https://orcid.org/0009-0008-2877-4637
Sanjana ShastriDepartment of Behavioral Neuroscience, Northeastern University, Boston, Massachusetts, USA.ORCID https://orcid.org/0009-0004-8245-8249
Ke WenDepartment of Chemical Engineering, Northeastern University, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0001-5202-6948
Eno E EbongDepartment of Chemical Engineering, Northeastern University, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0001-9483-1443

Funding

National Science Foundation (NSF) CMMI 1846962National Science Foundation (NSF) HRD 1812412
6 · The paper itself

Abstract

Cancer metastasis is the leading cause of death for those afflicted with cancer. In cancer metastasis, the cancer cells break off from the primary tumor, penetrate nearby blood vessels, and attach and extravasate out of the vessels to form secondary tumors at distant organs. This makes extravasation a critical step of the metastatic cascade. Herein, with a focus on triple-negative breast cancer, the role that the prospective secondary tumor microenvironment's mechanical properties play in circulating tumor cells' extravasation is reviewed. Specifically, the effects of the physically regulated vascular endothelial glycocalyx barrier element, vascular flow factors, and subendothelial extracellular matrix mechanical properties on cancer cell extravasation are examined. The ultimate goal of this review is to clarify the physical mechanisms that drive triple-negative breast cancer extravasation, as these mechanisms may be potential new targets for anti-metastasis therapy.

Indexed as

GlycocalyxTriple Negative Breast NeoplasmsTumor MicroenvironmentAnimalsEndothelium, VascularFemaleHumansNeoplasm MetastasisNeoplastic Cells, Circulatingcancer cell extravasationendothelial cellsextracellular matrixglycocalyxtissue stiffnessvascular flow

Identifiers

PMID38949120
PMCPMC13688231

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.